This time, we draw your attention to inspiring business opportunities from biotechnology and medical device companies. We also discuss Vienna’s broad expertise in cancer research both in academia and as regards promising new drug candidates. You are also invited to find out more about how microparticles developed at the Austrian Centre of Industrial Biotechnology in Vienna help to bring protein production at Boehringer Inhgelheim’s BioXcellence to the next level. Innovations linked to fully automated blood analyses in Vienna’s hospitals also take center stage in one of the articles in the spring edition of our biannual publication.
LISAvienna Highlights 01/2015
LISAvienna Highlights published
The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.
As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.